Normal view MARC view ISBD view

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management.

Movva, Sujana

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab (MDX-010), a novel treatment strategy in cancer management. [electronic resource] - Expert opinion on biological therapy Feb 2009 - 231-41 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7682

Standard No.: 10.1517/14712590802643347 doi

Subjects--Topical Terms:
Antibodies, Monoclonal--immunology
Antigens, CD--immunology
Antineoplastic Agents--immunology
CTLA-4 Antigen
Humans
Ipilimumab
Neoplasms--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)